Abstract:Background Gliomas are one of the most common malignant brain tumors and bring a big threat to human life as traditional therapy is unsatisfactory. RBM5 was a RNA-binding motif protein and was reported as a tumor suppressor. But the role of RBM5 in gliomas was unknown. Methods The mRNA level of RBM5 was determined in gliomas tissues and cell lines by real-time quantitative PCR (qRT-PCR) assay while the association of RBM5 expression with prognosis was analyzed by Kaplan-Meier method and compared by log-rank test. Lentivirus was used to overexpress RBM5 in gliomas cells. MTT and BrdU incorporation assay were used to determine cell proliferation and DNA synthesis when the ability of cell migration and invasion was analyzed by transwell assay with/without Matrigel. Cell apoptosis rate was determined with fluorescence-activated cell sorting (FACS) method. Then, expression of apoptosis molecules and critical members in Wnt/β-catenin pathway were detected by western blot analysis. Results RBM5 was shown to be downregulated in gliomas tissues and gliomas cell lines. And decreased RBM5 expression was clinically correlated with tumor stage, patient age, and poor prognosis of gliomas patients. The proliferation and DNA synthesis was dramatically inhibited when RBM5 was overexpressed in SHG44 or U251 cells. Also, the ability of cell migration and invasion was disrupted. Then, the level of β-catenin and Cyclin D1 significantly decreased when DKK1 and P-GSK-3β increased reversely in SHG44 cells, which suggested that RBM5 inhibited canonical Wnt/β-catenin signaling. Meanwhile, we demonstrated that caspase3-mediated apoptotic pathway was activated by RBM5 as Bax, TNF-α, and cleaved caspase3 were greatly upregulated while antiapoptotic molecule Bcl-2 was downregulated. Additionally, that apoptotic rate increased significantly from less than 1 to 32% in RBM5-overexpressed SHG44 cells further supported the pro-apoptosis role of RBM5 in gliomas cells. Conclusions RBM5 plays a suppressor role in human gliomas by inhibiting Wnt/β-catenin signaling and inducing cell apoptosis. This study improves our knowledge about the carcinogenesis and progression of human gliomas, which would greatly contribute to the therapy for gliomas patients.

Inhibition of Metabotropic Glutamate Receptor 5 Facilitates Hypoxia-Induced Glioma Cell Death

Mglur5 is Involved in Proliferation of Rat Neural Progenitor Cells Exposed to Hypoxia with Activation of Mitogen-Activated Protein Kinase Signaling Pathway

The Positive Feedback Loop Between RLIP76 and HIF-1α Promotes Glycolysis and Tumorigenesis in Glioma Cells Under Hypoxic Conditions

Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis with Inhibition of Gli-1 in Human Glioblastoma Cells.

Mglur5 Regulated Proliferation of Neural Stem Cells after Hypoxia with Activation of MAPK Signaling Pathway

Small-molecule Molephantin induces apoptosis and mitophagy flux blockage through ROS production in glioblastoma

Increased oxygen stimulation promotes chemoresistance and phenotype shifting through PLCB1 in gliomas

PDCD5 Promotes Cisplatin-Induced Apoptosis of Glioma Cells Via Activating Mitochondrial Apoptotic Pathway

DR5 Related Autophagy Can Promote Apoptosis in Gliomas after Irradiation.

Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma

Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6

Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas

Mitochondrial K ATP Channels Control Glioma Radioresistance by Regulating ROS-Induced ERK Activation

Microarray Analysis of the Hypoxia-induced Gene Expression Profile in Malignant C6 Glioma Cells

The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

Advances in the Targeting of HIF-1α and Future Therapeutic Strategies for Glioblastoma Multiforme

Regulated cell death in glioma: promising targets for natural small-molecule compounds

Inhibition of PRMT5 Attenuates Cerebral Ischemia/reperfusion–induced Inflammation and Pyroptosis Through Suppression of NF–κB/NLRP3 Axis

Metabotropic Glutamate Receptor 5 Promotes Proliferation of Human Neural Stem/Progenitor Cells with Activation of Mitogen-Activated Protein Kinases Signaling Pathway in Vitro

RBM5 Inhibits Tumorigenesis of Gliomas Through Inhibition of Wnt/β-catenin Signaling and Induction of Apoptosis

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma